Twitter account for the University of Virginia Department of Medicine.
Charlottesville, VA
Joined August 2019
- Tweets2.4K
- Following455
- Followers1.6K
- Likes5.1K
UVA Department of Medicine retweeted
AI can name a condition. Deciding what to do next, and answering for it, still takes a clinician.
📙 @UVA’s Dr. Andrew Parsons & @harvardmed's Dr. Adam Rodman in @AnnalsofIM: bit.ly/4yaSDJ3
ALT The image shows a person with folded arms standing outdoors, wearing a shirt and tie. Text on the image reads "University of Virginia School of Medicine" and "Commentary on Responsibilities Doctors Must Never Delegate to AI" under the heading "Research."
UVA Department of Medicine retweeted
The Ozempidemic — is social media telling the full story? cavalierdaily.com/article/20…
UVA Department of Medicine retweeted
Our paper is out in @ThoraxBMJ by @UVABME PhD graduate David Csordas in @PeirceLab! Olink-derived microvascular-proteomic signature predicts disease severity and survival in IPF. Great collaboration between @UvaDOM & @UVABME
thorax.bmj.com/content/early…
UVA Department of Medicine retweeted
Congratulations to IGNITE @Virginia_KUH trainee, Madison Williams, mentored by Brant Isakson, for presenting her poster " Pannexin 1 intracellular loop motif Y198 influences renal hemodynamics" at the KUHR-TN National Conference! @UVANeph @UvaDOM
UVA Department of Medicine retweeted
Excited to present preliminary findings from the phase 2b FORTIFY trial at #ESC2026.
Despite well-controlled CV risk factors, low hsCRP & excellent secondary prevention after a prior type 1 MI (median 2.6 years prior to enrollment), coronary inflammation remains strikingly prevalent: 63% had ≥1 artery with elevated FAI (>50th %tile) and 24% had 2 arteries >50th percentile in the screened population.
UVA Department of Medicine retweeted
Risk + Accountability and the Clinician’s Role in the AI Era @AnnalsofIM along with @adamrodmanMD #ManagementReasoning @ariseainetwork acpjournals.org/doi/10.7326/…
UVA Department of Medicine retweeted
How do learners struggle with management reasoning? Where is it more likely to occur? How is it best identified?
Our new study identifies phenotypes of struggle to inform remediation. Thanks to all the PDs and CCC chairs that participated. @pmeded #Meded #HPE #PhD @UvaDOM @MedicineUVA @uvahealthnews @UVaSOMFacDev @UVaGMEO
pmejournal.org/articles/10.5…
UVA Department of Medicine retweeted
What an experience presenting on the #AMEE2026 main stage with a wonderful group @vschaye @AdamRodmanMD @andrewolsonmd @LauraZwaan81 and Michelle Daniel. @AMEE_community #AI #CR #HPE @UvaDOM @uvahealthnews @MedicineUVA
UVA Department of Medicine retweeted
We are hosting a PT/OT symposium in October in Charlottesville @UVaCME @UvaDOM, inviting all healthcare professionals and rehab specialists interested in learning more about EDS and HSD. In-person only. uva.cloud-cme.com/course/cou…
UVA Department of Medicine retweeted
Proud of our @uvasrip @UVACVRC students presenting a poster at the #AHABCVS2026 in Boston, MA on #takotusbo (1/2)
UVA Department of Medicine retweeted
Congratulations 👏to @Virginia_KUH trainee Liz Thompson for presenting her work on "Fairness of Treatment Decisions for Vulnerable Patients in CKD" under guidance of Dr Julia Scialla @ERAkidney European Renal Association Congress 2026 @UVANeph @UvaDOM @MarkOkusa @PopovicsPetra
UVA Department of Medicine retweeted
Excellent work @WaqasHaiderMD @JCVPOnline - a practical statement, ready to use - I enjoyed work with you and the others pericarditis docs @UVACVRC @UvaDOM
Grateful to share our expert opinion in Journal of Cardiovascular Pharmacology.
This one was a true labor of love because it came directly from the questions we hear so often from patients with recurrent pericarditis: “What does life look like on IL-1 blockade?”
How worried should I be about infection? Vaccines? Work? Travel? Masking? Daily life?
Our message: for most patients, IL-1 blockade should mean thoughtful precautions and a return to normalcy, not unnecessary restriction.
Proud to have worked on this with an outstanding multidisciplinary group.
doi.org/10.1097/FJC.00000000…
UVA Department of Medicine retweeted
Aspirin in primary prevention: a case for selective use
pubmed.ncbi.nlm.nih.gov/4235…
A good clinical question, a medical student-led effort, an opportunity to discuss with some good clinical colleagues. @UvaDOM @CardioUva @UVACVRC @ToddVillinesMD
UVA Department of Medicine retweeted
What an amazing experience engaging with cardiologists from Egypt and around the world. Bravo #cardioAlex26! Until next time...
UVA Department of Medicine retweeted
Professor Vanessa Shami Editor-in-Chief of @Clin_endosc a leading international journal and the official journal of KSGE - kicking off IDEN 2026! @uvagastro @uvaDOM @medicineuva
UVA Department of Medicine retweeted
A group of @AmericanCancer experts, led by UVA Health cancer prevention expert Andrew Wolf, MD, is endorsing two new types of stool tests and advising doctors to recommend blood tests only to patients who won't pursue other options. More: bit.ly/4wYEBuO @UVACancerCenter
ALT The image shows a medical illustration of a human torso with the intestines highlighted in red, indicating inflammation or focus areas, under the title "Updated Colorectal Cancer Guidelines Endorse New Stool Tests." The UVA Health logo is visible at the top.
UVA Department of Medicine retweeted
We had a great first day of the 2026 BDSIL: UVA Edition! It was packed to the brim with lots of new connections, inspiring presentations, and fun activities. We can't wait for the rest of the week! 🎉 #BDSIL2026 #BDSILuvaedition #InnovationLab @uvadatascience @UvaDOM @uvamedicine
UVA Department of Medicine retweeted
Day 2 of the 2026 BDSIL: UVA Edition was a success! 🎉 We are looking forward to seeing how all of the innovative ideas continue to develop in the second half of the week! #BDSIL2026 #BDSILuvaedition #InnovationLab @uvadatascience @UvaDOM @uvamedicine
UVA Department of Medicine retweeted
Ken Walsh, PhD, and collaborators received $3.3 million from the NIH to study how men losing their Y chromosomes over time can contribute to heart failure. Congratulations Ken, @AmitRPatelMD, & Mohammad Abuannadi, MD!
cvrc.virginia.edu/walshhfpef…
UVA Department of Medicine retweeted
Coronary plaque in younger women may carry a far greater prognostic signal than equivalent plaque in men.
In our editorial in the Am Journal of Preventive Cardiology (doi.org/10.1016/j.ajpc.2026.…), we discuss why sex-specific interpretation of CCTA findings is essential—and why even “mild” plaque in women should prompt aggressive prevention efforts.
#CardioTwitter #CCTA #WomensHeartHealth
